Fmr LLC Janux Therapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 8,888,742 shares of JANX stock, worth $234 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,888,742

Previous 8,884,072 0.05%

Holding current value

$234 Million

Previous $240 Million 14.4%

% of portfolio

0.01%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$22.62 - $33.2 $105,635 - $155,044	4,670 Added 0.05%	8,888,742 $205 Million
Q1 2025 May 12, 2025	BUY	$27.0 - $57.81 $5.78 Million - $12.4 Million	214,131 Added 2.47%	8,884,072 $240 Million
Q4 2024 Feb 13, 2025	BUY	$40.18 - $66.83 $34 Million - $56.5 Million	845,266 Added 10.8%	8,669,941 $464 Million
Q3 2024 Nov 13, 2024	BUY	$35.29 - $50.26 $1.66 Million - $2.37 Million	47,075 Added 0.61%	7,824,675 $355 Million
Q2 2024 Aug 13, 2024	BUY	$35.12 - $64.78 $1 Million - $1.85 Million	28,591 Added 0.37%	7,777,600 $326 Million
Q1 2024 May 13, 2024	BUY	$7.93 - $49.75 $24.4 Million - $153 Million	3,077,796 Added 65.89%	7,749,009 $292 Million
Q4 2023 Feb 13, 2024	SELL	$5.85 - $11.7 $9.83 Million - $19.7 Million	-1,680,109 Reduced 26.45%	4,671,213 $50.1 Million
Q3 2023 Nov 13, 2023	BUY	$9.56 - $14.0 $12.3 Million - $18 Million	1,288,526 Added 25.45%	6,351,322 $64 Million
Q2 2023 Aug 11, 2023	SELL	$11.08 - $15.92 $862,555 - $1.24 Million	-77,848 Reduced 1.51%	5,062,796 $60.1 Million
Q1 2023 May 11, 2023	SELL	$11.25 - $22.21 $5.23 Million - $10.3 Million	-465,216 Reduced 8.3%	5,140,644 $62.2 Million
Q4 2022 Feb 13, 2023	SELL	$11.1 - $18.26 $7.12 Million - $11.7 Million	-641,532 Reduced 10.27%	5,605,860 $73.8 Million
Q3 2022 Nov 10, 2022	BUY	$10.82 - $16.84 $4.56 Million - $7.1 Million	421,688 Added 7.24%	6,247,392 $84.6 Million
Q2 2022 Aug 12, 2022	BUY	$9.52 - $15.65 $1.42 Million - $2.33 Million	148,778 Added 2.62%	5,825,704 $71.1 Million
Q1 2022 May 13, 2022	BUY	$13.24 - $20.24 $9.08 Million - $13.9 Million	685,524 Added 13.73%	5,676,926 $81.4 Million
Q4 2021 Feb 14, 2022	BUY	$15.44 - $27.32 $21.2 Million - $37.6 Million	1,375,971 Added 38.06%	4,991,402 $98.5 Million
Q3 2021 Nov 15, 2021	BUY	$20.7 - $34.69 $36.7 Million - $61.5 Million	1,771,867 Added 96.11%	3,615,431 $78.2 Million
Q2 2021 Aug 13, 2021	BUY	$18.58 - $25.37 $34.3 Million - $46.8 Million	1,843,564 New	1,843,564 $46 Million

Others Institutions Holding JANX

# of Institutions

186

Shares Held

56M

Call Options Held

869K

Put Options Held

652K

View Full List

About Janux Therapeutics, Inc.

Ticker JANX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,663,000
Market Cap $1.1B
Description
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...

More about JANX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account